Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans
Ghrelin possesses endocrine and non-endocrine actions mediated by the GH Secretagogue (GHS)-Receptors (GHS-R). The regulation of ghrelin secretion is still largely unknown. Somatostatin (SRIF) modulates central and gastroenteropancreatic hormonal secretions and functions. SRIF actions are partially shared by cortistatin (CST), a natural SRIF analogue, that binds all SRIF receptors and also GHS-R. Herein, we studied the effects of SRIF-14 or CST-14 (2.0 μg/kg/h i.v. over 120 min) and of placebo on ghrelin, GH, insulin, glucagon and glucose levels in 6 normal young men. Placebo unaffected GH, insulin, glucagon, glucose and ghrelin levels. SRIF and CST similarly inhibited (p<0.05) spontaneous GH secretion of about 90%. After SRIF or CST withdrawal, GH levels recovered to baseline levels. Both SRIF and CST similarly inhibited (p<0.01) insulin secretion of about 45%. In both sessions, after SRIF or CST withdrawal, insulin overrode baseline levels. Both SRIF and CST similarly inhibited (p<0.01) glucagon levels of about 40%. After SRIF or CST withdrawal, glucagon persisted lower (p<0.05) than at baseline. Neither SRIF nor CST modified glucose levels. Both SRIF and CST similarly inhibited (p<0.01) circulating ghrelin levels of about 55%. Ghrelin levels progressively decreased from time +15 min, reaching the nadir at 120 and 105 min for SRIF and CST, respectively. Even 30 min after SRIF or CST withdrawal, ghrelin levels persisted lower (p<0.05) than those at baseline. In conclusion, this study first shows that SRIF and CST strongly inhibits ghrelin secretion that, differently from GH and insulin secretion, persists inhibited even after stopping the infusion of SRIF or CST.
|Persistent URL||dx.doi.org/10.1210/jc.2002-020956, hdl.handle.net/1765/55759|
|Journal||Journal of Clinical Endocrinology and Metabolism|
Broglio, F, Deghenghi, R, Arvat, E, van der Lely, A-J, Ghigo, E, van Koetsveld, P.M, … Hofland, L.J. (2002). Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. Journal of Clinical Endocrinology and Metabolism, 87(10), 4829–4832. doi:10.1210/jc.2002-020956